% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Wenning:163952,
author = {Wenning, Gregor K and Stankovic, Iva and Vignatelli, Luca
and Fanciulli, Alessandra and Calandra-Buonaura, Giovanna
and Seppi, Klaus and Palma, Jose-Alberto and Meissner,
Wassilios G and Krismer, Florian and Berg, Daniela and
Cortelli, Pietro and Freeman, Roy and Halliday, Glenda and
Höglinger, Günter and Lang, Anthony and Ling, Helen and
Litvan, Irene and Low, Phillip and Miki, Yasuo and Panicker,
Jalesh and Pellecchia, Maria Teresa and Quinn, Niall and
Sakakibara, Ryuji and Stamelou, Maria and Tolosa, Eduardo
and Tsuji, Shoji and Warner, Tom and Poewe, Werner and
Kaufmann, Horacio},
title = {{T}he {M}ovement {D}isorder {S}ociety {C}riteria for the
{D}iagnosis of {M}ultiple {S}ystem {A}trophy.},
journal = {Movement disorders},
volume = {37},
number = {6},
issn = {0885-3185},
address = {New York, NY},
publisher = {Wiley},
reportid = {DZNE-2022-00626},
pages = {1131-1148},
year = {2022},
note = {(CC BY)},
abstract = {The second consensus criteria for the diagnosis of multiple
system atrophy (MSA) are widely recognized as the reference
standard for clinical research, but lack sensitivity to
diagnose the disease at early stages.To develop novel
Movement Disorder Society (MDS) criteria for MSA diagnosis
using an evidence-based and consensus-based methodology.We
identified shortcomings of the second consensus criteria for
MSA diagnosis and conducted a systematic literature review
to answer predefined questions on clinical presentation and
diagnostic tools relevant for MSA diagnosis. The criteria
were developed and later optimized using two Delphi rounds
within the MSA Criteria Revision Task Force, a survey for
MDS membership, and a virtual Consensus Conference.The
criteria for neuropathologically established MSA remain
unchanged. For a clinical MSA diagnosis a new category of
clinically established MSA is introduced, aiming for maximum
specificity with acceptable sensitivity. A category of
clinically probable MSA is defined to enhance sensitivity
while maintaining specificity. A research category of
possible prodromal MSA is designed to capture patients in
the earliest stages when symptoms and signs are present, but
do not meet the threshold for clinically established or
clinically probable MSA. Brain magnetic resonance imaging
markers suggestive of MSA are required for the diagnosis of
clinically established MSA. The number of research
biomarkers that support all clinical diagnostic categories
will likely grow.This set of MDS MSA diagnostic criteria
aims at improving the diagnostic accuracy, particularly in
early disease stages. It requires validation in a
prospective clinical and a clinicopathological study. ©
2022 The Authors. Movement Disorders published by Wiley
Periodicals LLC on behalf of International Parkinson and
Movement Disorder Society.},
subtyp = {Review Article},
keywords = {Brain: pathology / Consensus / Humans / Magnetic Resonance
Imaging / Multiple System Atrophy: diagnosis / Multiple
System Atrophy: pathology / Prospective Studies / diagnosis
(Other) / diagnostic criteria (Other) / multiple system
atrophy (Other)},
cin = {AG Höglinger 2},
ddc = {610},
cid = {I:(DE-2719)1111015},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pmc = {pmc:PMC9321158},
pubmed = {pmid:35445419},
doi = {10.1002/mds.29005},
url = {https://pub.dzne.de/record/163952},
}